Exane Derivatives’s ChemoCentryx, Inc. CCXI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $2.28K | Hold |
92
| – | – | ﹤0.01% | 426 |
|
|
2022
Q1 | $2.31K | Hold |
92
| – | – | ﹤0.01% | 739 |
|
|
2021
Q4 | $3.35K | Sell |
92
-18,314
| -100% | -$667K | ﹤0.01% | 628 |
|
|
2021
Q3 | $315K | Sell |
18,406
-538
| -3% | -$9.2K | 0.08% | 269 |
|
|
2021
Q2 | $309K | Sell |
18,944
-2,061
| -10% | -$33.6K | 0.07% | 274 |
|
|
2021
Q1 | $1.08M | Buy |
21,005
+991
| +5% | +$50.8K | 0.31% | 72 |
|
|
2020
Q4 | $1.24M | Buy |
20,014
+18,220
| +1,016% | +$1.13M | 0.36% | 53 |
|
|
2020
Q3 | $98.3K | Buy |
1,794
+182
| +11% | +$9.97K | 0.03% | 284 |
|
|
2020
Q2 | $92.7K | Sell |
1,612
-517
| -24% | -$29.7K | 0.02% | 288 |
|
|
2020
Q1 | $85.5K | Buy |
+2,129
| New | +$85.5K | 0.02% | 284 |
|